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ABSTRACT
Objectives: The objective of this study was to evaluate the drug prescribing trends in the intensive care unit (ICU) and correlate them with the disease 
patterns and patients’ outcomes.
Methods: The case records of patients admitted to the ICU at Sultan Qaboos University Hospital, a teaching hospital in Oman, during a 5-month period 
between June 1st and October 31st 2013 were analyzed. The variables collected included demographic and clinical characteristics as well as duration 
of hospitalization, indications, and utilization of different drugs.
Results: A total of 138 patients were evaluated with an average age of 46±19 years. The average length of stay at ICU was 4.5±3.5 days. The average 
number of drugs per prescription was 8.0±4.6. The most common route used was the parenteral route (66%) followed by the enteral route (25%). 
Anti-infective drugs were the most commonly prescribed class of drugs (25%) followed by gastrointestinal drugs (20%). Antibiotics accounted for 
12% of the total drugs prescribed. Trauma was the most common indication for the admission to the ICU (22%).
Conclusion: Drugs prescription patterns in the ICU appeared to be similar to those reported in previous studies. However, prescription protocols 
need to be addressed to guide appropriate use of drugs in the ICU setting.
Keywords: Drug utilization, Critical care, Pattern, Oman.
INTRODUCTION
Problems associated with drug prescription are not uncommon 
worldwide. Prescribing errors are considered as a key threatening 
factor that affects patient safety throughout hospital practice. The main 
problems are medication errors and adverse drug events [1]. A meta-
analysis of 35 studies between 1990 and 2005 indicated that medication 
errors occurred at an average rate of 5.7% of all drug administration 
episodes while adverse drug events affected, on average, 6.1 patients 
per 100 hospitalized [1]. A set of core drug use indicators has been 
compiled by the World Health Organization (WHO), which are useful 
for studying patterns of drug prescribing in health-care facilities. These 
indicators include average number of drugs per encounter, percentage 
of drugs prescribed by generic name, percentage of encounters with an 
antibiotic, percentage of encounters with an injection, and percentage 
of drugs prescribed from the essential drug list [2].
The intensive care unit (ICU) is a setting where most patients with 
serious diseases are admitted. Therefore, a large number of drugs 
are employed to save these patients and that make them susceptible 
to medication errors and adverse drug reactions [3]. According to 
the comparison held by Weber et al., 38% of the total drug costs are 
accounted for the ICU and these costs have increased at greater rate 
against non-ICU drug costs [4]. Furthermore, the cost of hospitalization 
and drug treatment in the ICU are also high [5].
Since patients admitted to the ICU receive multiple drugs, the majority 
of these drugs are empirically prescribed and mainly based on physician 
previous experience resulting in the lack of quantitative precision of 
drugs usage [6]. For example, some European reviews have indicated that 
over 50% of all neonatal ICU patients received off-label or an unlicensed 
prescription [7]. Several studies correlated multiple factors with mortality 
and duration of hospitalization in the ICU. Bobek et al. showed that 
the number of medication classes was a significant independent factor 
associated with the length of stay in the ICU [8]. A study by Hartmann 
et al. reported that antibiotic therapy correlates with hospital mortality 
in patients staying for more than 24 hrs in a surgical ICU [9].
Even with the presence of drug use guidelines and policies in the 
ICU, it might be difficult to apply them due to the patient-specific 
disease state and physician medication preferences [8]. To improve 
therapeutic practices in such a case, it was found that the application of 
simple techniques of drug utilization was useful and inexpensive [10]. 
Therefore, utilization trends and costs of drugs prescribed in the ICU 
need to be urgently addressed.
Currently, there are no local data on drug prescribing trends of doctors 
at the ICU of Sultan Qaboos University Hospital (SQUH), a tertiary 
care teaching hospital in Oman. The aim of the current study was to 
evaluate the drug utilization pattern and prescribing trends in the ICU 
at SQUH and correlate them with disease patterns and patients’ clinical 
outcomes. Studying drug prescribing pattern in the ICU is critically 
important in guiding prescription practices, and therefore, will help in 
ensuring an optimal outcome and containing costs.
METHODS
Design and setting
The study was conducted in the ICU at SQUH, a tertiary care hospital in 
the Sultanate of Oman. At SQUH, the ICU is part of the Department of 
Anesthesia, Intensive Care and Pain Management. The department has 
20 adult beds that include coronary care unit also.
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This was a retrospective cross-sectional study of the case records 
of all patients admitted to the ICU at SQUH during the period from 
1st June 2013 to 31st October 2013. Patients who stayed for a long-term 
(>20 days) and patients who stayed <24 hrs in the ICU were excluded 
from the study.
Data collection
The collected patients’ data included demographics (name, gender, 
age and weight), differential diagnoses on admission, duration of 
hospitalization in the ICU, final diagnoses, and patient’s clinical outcome. 
Medication prescription details were also collected including number 
of drugs prescribed on the day of admission, administered doses, route 
of administration, and class/name of medications prescribed for each 
patient.
Ethical approval was obtained from the Medical Research and Ethics 
Committee of the College of Medicine and Health Sciences at Sultan 
Qaboos University. This approval provides permission to utilize 
patients’ data in a confidential manner without disclosing patients’ 
details.
Statistics
Descriptive statistics were used to describe the data. For categorical 
variables, frequencies and percentages were reported. For continuous 
variables, the means and standard deviations were used to summarize 
the data. The analyses were performed using Pearson’s Chi-square 
tests, Student’s t-test, and Mann–Whitney test whenever appropriate. 
Statistical significance was fixed at the level of p<0. Analyses were 
performed using Stata (Stata Corp LP, College Station, TX, USA).
RESULTS
Patients characteristics
This study analyzed 138 patient admissions with a total of 
1098 prescriptions. The average age of the patients was 46±19 years. 
The most frequent age was 21-40 years group (37%, n=51), with males 
representing 64% (n=88) of all patients. The mean of duration of stay 
in the ICU was 4.5±3.5 days. The median drug treatment duration of the 
patients was 7.0 days (Table 1).
As shown in Table 2, the WHO core drug prescribing indicators 
included the average number of drugs per prescription was 8.0±4.6, 
the percentage of injectable drug use was 66%, and the percentage 
of antibiotics use was 12%. In addition, out of 160 drugs, 77 (48%) 
belonged to the WHO essential drug list.
Drug prescribing indicators
A total of 160 drugs (1098 prescriptions) were prescribed during the 
period of stay in the ICU. The average number of drugs prescribed per 
patient was 8.0±4.6. The parenteral route was the most commonly 
prescribed route of drug administration (66%) followed by enteral 
route (26%) and then inhalation which accounted for 3.3% of the total 
drug prescriptions (N=1098).
Table 3 shows a list of the top common prescribed drugs. Omeprazole 
was the most frequently prescribed medication (n=74, 6.7%) followed 
by enoxaparin (n=67, 6.1%), paracetamol (n=51, 4.6%), ranitidine, 
tramadol (n=38, 3.5%), tazocin (n=35, 3.2%), and meropenem (n=33, 
3.0%).
As shown in Fig. 1 below, anti-infective drugs were the most commonly 
administered classes of drugs (25%) followed by gastrointestinal 
drugs (20%), medicine affecting the blood (10%), and cardiovascular 
drugs (8.8%).
Disease pattern and patients’ clinical outcome
The diagnoses of patients admitted to the ICU were further categorized 
and are shown in Fig. 2. The majority of patients had trauma (22%) 
followed by cardiovascular (13%), gastrointestinal system’s diseases 
Table 1: Demographic/clinical characteristics of patients during 
ICU stay
Clinical characteristics Parameter
Total number of patients (N) 138
Age, mean±SD, (years) 46±19
Age groups, years (n)
Up to 20 7
21-40 51
41-60 43




Weight*, mean±SD, kg 68±19
Duration of stay at ICU, days (mean±SD) 4.5±3.5
Number of drugs prescribed/patient (mean±SD) 8.0±4.6
Drug treatment duration, days (median) 7
*Missing 26. SD: Standard deviation, ICU: Intensive care unit
Table 2: WHO core prescribing indicators (N=138)
Indicator Parameter
Average number of drugs per encounter, mean±SD 8.0±4.6
Percentage of encounters with an antibiotic 12%
Percentage of encounters with an injection 66%
Percentage of drugs prescribed from the essential 
drug list
48%
SD: Standard deviation, WHO: World Health Organization
Table 3: List of the top common prescribed drugs in the 
intensive care unit (N=1098 prescriptions)




Omeprazole Parenteral 74 (6.70)
Enoxaparin Parenteral 67 (6.10)
Paracetamol Enteral/parenteral 51 (4.60)
Ranitidine Enteral/parenteral 38 (3.50)
Tramadol Enteral/parenteral 38 (3.50)
Tazocin Parenteral 35 (3.20)
Meropenem Parenteral 33 (3.00)
Nonformulary drug Parenteral 32 (2.90)
Ceftriaxone Parenteral 31 (2.80)
Vancomycin Parenteral 24 (2.20)
Potassium chloride Enteral/parenteral 24 (2.20)
(13%), and infections (8.0%). Regarding the outcomes of patients 
during their stay in the ICU, about 75% of the patients were shifted to 
the general wards while 25% were deceased.
Associations of drugs patterns and outcomes
The difference in the clinical outcome with the total number of drugs 
prescribed per patient as well as the length of stay in the ICU was 
statistically significant (p=0.023 and 0.004, respectively). No significant 
associations were noted between clinical outcome and age as well as 
between clinical outcome and gender (p>0.05).
DISCUSSION
The present study evaluated drug utilization patterns in the ICU at 
SQUH. ICU is a setting where seriously ill patients who often suffer from 
multiple organ dysfunctions are administered. Therefore, the number 
of prescribed drugs and the cost of treatment and hospitalization are 
usually high [11]. Periodic studies on drug utilization are useful to 
meet the needs of assessing drug prescribing trends and optimizing 
pharmacotherapy.
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The demographic data of 138 patients admitted to the ICU during the 
five months study period revealed that the mean age of the patients 
was 46±19 years, with males representing 64% of the patients. This 
finding was similar to the two studies conducted in eastern and 
southern India in 2007 and 2011 [12-14]. Another study by Smythe 
et al. documented equal number of male and female individuals 
admitted to the ICU; however, with a significantly higher average age 
of 65 years [15]. Previous Iranian studies have reported that male 
patients accounted for more cases than female patients (68% and 
32%, respectively) [16].
The most frequent age group was 21-40 years. This was in contrast to 
Shankar et al. study, which reported >49 years as the most frequent age 
group [5]. The mean length of stay of all patients admitted to the ICU was 
4.5 days. This was similar to a retrospective study conducted in Canada, 
which showed that the average duration of ICU stay was 4.7 days [3]. 
This number was significantly low compared with American and 
Iranian studies with 9.4 and 6.0 days, respectively [10,16]. Therefore, 
early discharge from ICU plays a major role in minimizing economic 
burden.
A total of 1098 prescriptions for 138 patients were included in the 
study. The average number of drugs per patient (encounter) was 8.0 
with a maximum number of 22 drugs per patient. This is lower or 
comparable to other previous studies. In an American study conducted 
in a trauma ICU, the average number of prescribed drugs was 9.1 [17] 
while an Indian study showed an average of 13.5 drugs [11]. A study in 
a French medical ICU reported that the average number of prescribed 
drugs was 5.0 [18]. By optimizing the administration of drugs within 
the ICU, the risk of drug-drug interactions and development of 
antibiotics resistance are minimized [19]. Therefore, it is important to 
keep number of prescribed drug as low as possible.
The WHO core indicators of prescribing practices measure the 
performance of health-care providers in several key dimensions 
related to the appropriate use of drugs. In our study, the percentage 
of antibiotics use was 12% and the percentage of injectable drug use 
was 66%. About 52% of drugs were prescribed from the WHO essential 
drug list. This finding was similar to the study from America that 
showed 50% of prescribed drugs used in the ICU either belong to the 
WHO essential drug list or complementary drug list [10].
The most frequent route of drugs administration found in the current 
study was the parenteral route (66%) followed by enteral route 
(26%). Intravenous administration accounted for the majority of the 
parenteral drugs. Results of other studies carried out in India and Nepal 
also documented that parenteral drugs were the most frequent routes 
of administration (87%, 51.12% and 53%, respectively) [5,11,20]. In 
contrast, Paudel et al. reported that oral tablets (48%) were the most 
commonly used dosage form in the ICU followed by injection and 
intravenous fluid (33% and 7.8 %, respectively) [19]. Since patients 
admitted to the ICU suffer from severe diseases and need rapid 
interventions, parenteral drugs were found to be the most frequently 
prescribed which provide immediate onset of action. This might be a 
possible explanation for our finding.
The most commonly prescribed drug was omeprazole (n=74; 6.7%), 
followed by enoxaparin (n=67; 6.1%) and paracetamol (n=51; 4.6%). 
A study in Western Nepal found that pantoprazole was the most 
frequently prescribed [19]. Among the ten most prescribed medicines, 
ranitidine was the most prescribed in another previous study [11]. 
Omeprazole is significantly important in suppressing gastric acid 
secretion, prevention of upper gastrointestinal bleeding, and promotion 
of mucosal healing. The present finding is sensible since endoscopic 
studies observed that between 75% and 100% of ICU patients had 
stress-related mucosal disease within 24 hrs of admission. As a result, 
administration of acid suppression therapy (e.g., omeprazole) for 
stress ulcer prophylaxis in the ICU is well recommended to prevent 
gastrointestinal bleeding [21]. Omeprazole and enoxaparin are 
prescribed to all intubated patients unless contraindicated to prevent 
gastrointestinal bleeding and deep vein thrombosis, respectively.
According to the classification of the WHO Model List of Essential 
Medicines, anti-infective agents were the most commonly administered 
class of drugs (25%). Within the anti-infective class, tazocin was the 
most prescribed drug. This was similar to a study performed in Iran in 
2010 [16]. However, an Indian study observed that anti-infective agents 
were the second most prescribed class among the top five dug classes in 
the ICU [13]. In view of the long period of stay and unconscious status of 
ICU patients, they are more prone to hospital-acquired infections which 
affect about 30% of ICU patients [22]. Singh et al. documented that 
20-30% of nosocomial infections in the hospital were contributed by 
the ICU [23]. This might be one of the probable reasons for the increase 
in the number of prescribed anti-infective agents.
The current study reported that trauma was the most common 
indication for the admission to the ICU (22%) followed by 
cardiovascular diseases, gastrointestinal diseases, and infections (15%, 
13% and 8.0%, respectively). As mentioned earlier, patients admitted 
to the ICU at SQUH were younger compared with another study [11]. 
Consequently, the risk of having traffic car accidents is higher than 
other older age groups. This might be one reason for the increase in 
the number of traumatic conditions managed in the ICU. In contrast, 
two previous publications found that cardiovascular conditions were 
Fig. 1: Classes of drugs prescribed in the intensive care unit 
(N=1098 prescriptions). NSAIDs: Non-steroidal anti-inflammatory 
drugs
Fig. 2: Diagnostic categories of patients in the intensive care unit 
(N=138 patients)
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the most frequently encountered in the ICU [11,19]. The contrast may 
be explained by the fact that the majority of cardiovascular cases are 
managed in a special cardiac care unit at SQUH.
Our results of the most frequent indications are corresponding with 
the common classes of drugs prescribed. Among 138 patients admitted 
to the ICU during the study period, 103 (75%) patients improved 
and were shifted to the general wards while 35 (25%) patients died. 
The present findings agreed with those reported in a prospective 
observational study where the mortality rate was accounted for 28% of 
the total patients admitted [13]. Since ICU patients have an emergency 
illness with serious complication and undergo multiple emergent 
interventions, they are vulnerable to experiencing adverse outcomes. 
However, our ICU patients appeared to have a higher mortality rate 
compared with two studies carried out in 2005 and 2011 (15% and 
17%, respectively) [5,19]. The current study demonstrated significant 
association between the total number of prescribed drugs and mortality 
as deceased patients received larger number of drugs (p=0.023). This 
was consistent with the findings documented in another study [16]. 
In contrast to other reports in the literature, the present study found 
no significant association between mortality with patients’ age and 
sex [24]. Moreover, the probability of death in our ICU was higher when 
duration of stay was long (p=0.004).
The ICU has a high prevalence of nosocomial infection and antibiotic 
resistance, resulting in an increasing number of administered 
antibiotics [22]. The current study found that antibiotics accounted 
for 12% of the total drugs prescribed. Tazocin was the most commonly 
prescribed agent among this class while metronidazole was reported 
as the most commonly prescribed agent in another study [19]. In 
comparison to previous reports conducted in Turkey and Nepal, 
this study demonstrated low rate of antibiotic exposure (30% and 
58%, respectively) [5,25]. Certain factors may contribute to the low 
prescription of antibiotics. Since the number of trauma patients 
admitted in our ICU was the highest, these patients were less likely to 
have comorbid complications that require antibiotics [3]. The mean 
duration of hospital stay in all patients was 4.5 days. This reduced the 
chances of exposure to the hospital environment and to the patients 
with infectious disease. However, further studies are needed to evaluate 
bacterial resistance trends in the ICU at SQUH.
Our study had its limitations. Being a retrospective study, the quality of 
data was dependent on the available records and the missing data were 
very common. The sample size is relatively small which may not fully 
reflect the accurate population characteristics. Moreover, assessment of 
financial burden of drugs consumption in the ICU was not addressed 
in our study.
CONCLUSION
In conclusion, the results of this audit evaluated the drug utilization 
trends in the ICU at SQUH. They appeared to be reasonable and similar 
to those reported in other previous studies. This study will provide 
a database for further researches that will determine the cost and 
patterns of drug use in the ICU. Prescription protocols need to be 
addressed to guide for appropriate use of drugs in the ICU setting.
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